胆管癌：来自泰国的经验教训。
Cholangiocarcinoma: lessons from Thailand.
作者信息
Sripa Banchob, Pairojkul Chawalit
机构信息
Department of Pathology, Faculty of Medicine, Thailand.
出版信息
Curr Opin Gastroenterol. 2008 May;24(3):349-56. doi: 10.1097/MOG.0b013e3282fbf9b3.
Abstract
PURPOSE OF REVIEW
To present the background of liver fluke-associated cholangiocarcinoma in Thailand focusing on recent epidemiological data and pathogenesis of this bile duct cancer.
RECENT FINDINGS
More systematic tumor registration in Thailand nowadays uncovers new high-incidence areas that are confined to not only the northeastern part but also some provinces in northern Thailand. The link between the liver fluke, Opisthorchis viverrini, and cholangiocarcinoma, particularly in terms of cellular and molecular pathogenesis, is further elucidated.
SUMMARY
Thailand is still the country with the highest incidence of cholangiocarcinoma in the world. Liver fluke induces chronic inflammation leading to oxidative DNA damage of the infected biliary epithelium and malignant transformation. Eradication of the fluke and identification of high-risk populations are urgently needed.
摘要
综述目的
介绍泰国肝吸虫相关胆管癌的背景，重点关注这种胆管癌的最新流行病学数据和发病机制。
最新发现
如今泰国更系统的肿瘤登记揭示了新的高发病区，这些地区不仅局限于东北部，还包括泰国北部的一些省份。肝吸虫华支睾吸虫与胆管癌之间的联系，特别是在细胞和分子发病机制方面，得到了进一步阐明。
总结
泰国仍然是世界上胆管癌发病率最高的国家。肝吸虫引发慢性炎症，导致受感染胆管上皮的氧化性DNA损伤和恶性转化。迫切需要根除肝吸虫并识别高危人群。
相似文献
1
Cholangiocarcinoma: lessons from Thailand.
Curr Opin Gastroenterol. 2008 May;24(3):349-56. doi: 10.1097/MOG.0b013e3282fbf9b3.
2
Opisthorchiasis and Opisthorchis-associated cholangiocarcinoma in Thailand and Laos.
Acta Trop. 2011 Sep;120 Suppl 1(Suppl 1):S158-68. doi: 10.1016/j.actatropica.2010.07.006. Epub 2010 Jul 23.
3
Roles of liver fluke infection as risk factor for cholangiocarcinoma.
J Hepatobiliary Pancreat Sci. 2014 May;21(5):301-8. doi: 10.1002/jhbp.62. Epub 2014 Jan 10.
4
Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
J Hepatobiliary Pancreat Sci. 2014 May;21(5):309-15. doi: 10.1002/jhbp.63. Epub 2014 Jan 10.
5
Liver flukes: the malady neglected.
Korean J Radiol. 2011 May-Jun;12(3):269-79. doi: 10.3348/kjr.2011.12.3.269. Epub 2011 Apr 25.
6
Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand.
Int J Cancer. 1994 Nov 15;59(4):505-9. doi: 10.1002/ijc.2910590412.
7
[Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
Bull Soc Pathol Exot. 2017 Feb;110(1):61-67. doi: 10.1007/s13149-017-0544-8. Epub 2017 Jan 19.
8
Liver fluke induces cholangiocarcinoma.
PLoS Med. 2007 Jul;4(7):e201. doi: 10.1371/journal.pmed.0040201.
9
Influence of misconceptions and inappropriate eating behaviors on Opisthorchis viverrini infection among at-risk populations undergoing cholangiocarcinoma screening in Northeastern Thailand.
Parasitol Res. 2023 Dec;122(12):3131-3138. doi: 10.1007/s00436-023-08003-1. Epub 2023 Oct 19.
10
Population-Based Intervention for Liver Fluke Prevention and Control in Meuang Yang District, Nakhon Ratchasima Province, Thailand.
Asian Pac J Cancer Prev. 2016;17(2):685-9. doi: 10.7314/apjcp.2016.17.2.685.
引用本文的文献
1
Immunomics-guided biomarker discovery for human liver fluke infection and infection-associated cholangiocarcinoma.
Nat Commun. 2025 Jul 1;16(1):5965. doi: 10.1038/s41467-025-61043-2.
2
Poly(d,l-lactide--glycolide) Nanoparticles Encapsulating Doxorubicin for Improved Treatment in Cholangiocarcinoma and Drug-Resistant Cells.
ACS Appl Bio Mater. 2025 Jun 18. doi: 10.1021/acsabm.5c00628.
3
Development of an efficacious oral peptide vaccine against infection with the carcinogenic liver fluke Opisthorchis viverrini.
Vaccine. 2025 Jun 17;61:127400. doi: 10.1016/j.vaccine.2025.127400.
4
Comparison of spatial prediction models from Machine Learning of cholangiocarcinoma incidence in Thailand.
BMC Public Health. 2025 Jun 7;25(1):2137. doi: 10.1186/s12889-025-23119-y.
5
The prognostic role of albumin-bilirubin grade in the mortality of extrahepatic cholangiocarcinoma patients.
BMC Gastroenterol. 2025 May 19;25(1):383. doi: 10.1186/s12876-025-03979-9.
6
Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma.
Sci Rep. 2025 May 18;15(1):17228. doi: 10.1038/s41598-025-02713-5.
7
One Health showcase from Asia: the Lawa model-a community-based approach to liver fluke control in Thailand.
Sci One Health. 2025 Mar 26;4:100108. doi: 10.1016/j.soh.2025.100108. eCollection 2025.
8
Updated cholangiocarcinoma incidence trends and projections in Thailand by region based on data from four population-based cancer registries.
Lancet Reg Health Southeast Asia. 2025 Mar 29;35:100569. doi: 10.1016/j.lansea.2025.100569. eCollection 2025 Apr.
9
A combined radiomics and clinical model for preoperative differentiation of intrahepatic cholangiocarcinoma and intrahepatic bile duct stones with cholangitis: a machine learning approach.
Front Oncol. 2025 Mar 17;15:1546940. doi: 10.3389/fonc.2025.1546940. eCollection 2025.
10
Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma.
Sci Rep. 2025 Mar 29;15(1):10886. doi: 10.1038/s41598-025-95142-3.
本文引用的文献
1
Cholangiocarcinoma and its management.
Gut. 2007 Dec;56(12):1755-6. doi: 10.1136/gut.2007.138859.
2
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
Clin Gastroenterol Hepatol. 2007 Oct;5(10):1221-8. doi: 10.1016/j.cgh.2007.05.020. Epub 2007 Aug 6.
3
Liver fluke induces cholangiocarcinoma.
PLoS Med. 2007 Jul;4(7):e201. doi: 10.1371/journal.pmed.0040201.
4
Incidence rates of intra- and extrahepatic cholangiocarcinomas in Denmark from 1978 through 2002.
J Natl Cancer Inst. 2007 Jun 6;99(11):895-7. doi: 10.1093/jnci/djk201.
5
Cholangiocarcinoma: emerging approaches to a challenging cancer.
Curr Opin Gastroenterol. 2007 May;23(3):317-23. doi: 10.1097/MOG.0b013e3280495451.
6
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
Am J Gastroenterol. 2007 May;102(5):1016-21. doi: 10.1111/j.1572-0241.2007.01104.x. Epub 2007 Feb 23.
7
Cancer statistics, 2007.
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66. doi: 10.3322/canjclin.57.1.43.
8
Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
Int J Cancer. 2007 Feb 1;120(3):638-41. doi: 10.1002/ijc.22283.
9
Ultrasound screening for Opisthorchis viverrini-associated cholangiocarcinomas: experience in an endemic area.
Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):431-3.
10
Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States.
Liver Int. 2006 Nov;26(9):1047-53. doi: 10.1111/j.1478-3231.2006.01350.x.
Zotero 插件